Diagnostic Case Study

The Dow Paradox.
Index Membership
vs. Fundamental Quality.

We ran a full cross-sector bankability diagnostic on all 30 components of the Dow Jones Industrial Average. The results reveal a significant divergence between index prestige and fundamental quality — with only 13 of 30 components scoring above the VIU Peer Index benchmark.

```
Universe 30 Issuers
Diagnostic Date March 30, 2026
VPI Benchmark 49.30
```
Top 8 — VIU Bankability Score™
Dow Jones 30 — Partial Preview
```
MSFT
Microsoft
69.2
AAPL
Apple
66.0
JNJ
Johnson & Johnson
63.4
NKE
Nike
63.0
XOM
ExxonMobil
62.6
...
25 more issuers
Download report
VIU Peer Index™
Benchmark Score
49.30
```
Key Findings

What the Diagnostic Revealed

The Dow Jones Industrial Average is the most watched index in the world. Inclusion criteria are based on reputation, size, and market influence — not fundamental quality. The VIU Diagnostic scores on Graham-calibrated fundamentals. The two are not the same standard.

13
of 30 components
Score above the VIU Peer Index benchmark of 49.30 — less than half of the most prestigious index in the world.
3
components below 30
Boeing (23.1), Goldman Sachs (28.3), and JPMorgan (34.3) — all household financial names — score in the stress zone.
46
point spread
From 69.2 (Microsoft) to 23.1 (Boeing) — within a single prestige index. Fundamental quality diverges sharply from index membership.
49.3
VIU Peer Index
The normalized benchmark across all 30 components. Only issuers above this threshold demonstrate above-average fundamental quality within this universe.
45.2
MMM score — rank 18
3M ranks 18th of 30 — below the peer benchmark — reflecting ongoing litigation exposure, margin compression, and balance sheet stress.
4 min
diagnostic time
The complete 30-issuer cross-sector diagnostic was produced in under 4 minutes. Traditional analyst equivalent: 10+ analyst days.

All 30 Components
Ranked on One Standard

Every Dow component scored on the same deterministic framework — normalized across sectors, accounting standards, and market contexts. Sector is not a factor. Only fundamentals.

Opportunity Zone — Score 57+
Above-benchmark fundamental quality. 13 components qualify.
Moderate Zone — Score 40–57
Below benchmark. Fundamental stress in one or more pillars. 14 components.
Stress Zone — Score below 40
Significant fundamental vulnerabilities identified. 3 components.
Opportunity Zone — Score 57+
1MSFTMicrosoft
69.2
2AAPLApple
66.0
3JNJJohnson & Johnson
63.4
4NKENike
63.0
5XOMExxonMobil
62.6
6PGProcter & Gamble
61.1
7CSCOCisco Systems
61.0
8CVXChevron
59.9
9CRMSalesforce
59.1
10MRKMerck
58.6
11TSLATesla
57.8
12AXPAmerican Express
57.2
13PFEPfizer
57.0
```
Moderate Zone — Score 40-57
14KOCoca-Cola
48.6
15MCDMcDonald's
48.2
16CMCSAComcast
46.3
17CATCaterpillar
45.9
18MMM3M Company ★
45.2
19IBMIBM
44.8
20UNHUnitedHealth
44.5
21AMGNAmgen
43.7
22HDHome Depot
43.5
23HONHoneywell
41.4
24RTXRTX Corp.
41.0
25DOWDow Inc.
38.5
26SBUXStarbucks
37.8
27INTCIntel
37.2
Stress Zone — Score Below 40
28JPMJPMorgan Chase
34.3
29GSGoldman Sachs
28.3
30BABoeing
23.1
Context Note

A low VIU Score reflects current fundamental stress — it does not constitute a sell recommendation. Boeing's score reflects its structural balance sheet challenges and ongoing operational recovery. Goldman and JPMorgan scores reflect financial sector characteristics including leverage profiles that differ from industrial issuers.

★ Primary Issuer

MMM (3M) was the primary issuer in this diagnostic run — ranked 18th with a score of 45.2, below the VPI benchmark of 49.30. Balance Sheet Strength shows elevated stress reflecting litigation liability exposure.

```
Diagnostic Framework

How the VIU Diagnostic Works

The VIU Diagnostic engine applies a deterministic 6-pillar framework — normalized across sectors, accounting regimes, and market contexts. Identical inputs always produce identical outputs. No analyst discretion. No subjective weighting.

I
Profitability
ROE · ROA · Gross Margin
Operating Margin · Net Margin
II
Balance Sheet Strength
Debt to Equity · Current Ratio
Leverage metrics
III
Cash Flow Quality
FCF to Debt
Operating Cash generation
IV
Growth & Efficiency
Revenue CAGR
EPS CAGR trajectory
V
Risk & Resilience
Altman-Z Score
Stress scenario modeling
VI
Dividend Coverage
Payout sustainability
Coverage ratios

"The VIU Diagnostic does not measure market momentum, analyst sentiment, or index prestige. It measures one thing only: the fundamental quality of an issuer's financial profile — on a normalized, deterministic, audit-ready standard. Sector is irrelevant. Exchange is irrelevant. Only fundamentals count."

— VIU ADVISORY CAPITAL MARKETS PRACTICE

Access the Full Diagnostic Reports

Two institutional-grade reports — produced for educational and analytical purposes. Complete rankings, methodology notes, and key diagnostic insights across all 30 Dow components.

```
Full Ranking Report
All 30 DJIA components ranked by VIU Bankability Score — color-coded by zone with score bars and exchange tags.
Analytical Brief
The Dow Paradox — key findings, score distribution, MMM issuer profile, diagnostic methodology, and important context notes.
Also Available

The VIU Bankability Brief™ — our weekly S&P 500 cross-sector diagnostic subscription — launches April 6, 2026. Early access available for institutional subscribers.

Access Platform →
Download Both Reports

Complete the form below to receive instant access to both diagnostic reports. No spam — institutional communications only.

Your information is used solely to deliver the requested reports and occasional VIU Capital institutional communications. We do not share or sell your data. By submitting you acknowledge these are educational diagnostic outputs and not investment advice.

Access Granted

Thank you. Your reports are ready for download below.
A confirmation has been sent to your email address.

Full Ranking Report — PDF Analytical Brief — PDF
Next Step

Interested in the VIU Bankability Brief™ weekly subscription or institutional platform access?

Contact Us →
```

Important Disclaimer: This case study and the associated diagnostic reports are produced for educational and informational purposes only. They do not constitute investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services. VIU Capital diagnostic outputs reflect current fundamental data and are not predictive of future performance. The VIU Bankability Score is a proprietary analytical measure and should not be used as the sole basis for any investment decision. All data is sourced from publicly available financial information. Past diagnostic accuracy does not guarantee future results. VIU Capital™ is a trademark of The VIU Inc. © 2026 The VIU Inc. All rights reserved. Unauthorized reproduction or redistribution is prohibited.